Senior Director, Process Chemistry & API Scale-Up

Initial Therapeutics, Inc.; Indianapolis (IN); On-site; USD 148,500 - 257,400; Full time

Benefits offered by this job

Comprehensive benefit program

401(k) participation

Flexible spending accounts

Job summary

Initial Therapeutics, Inc. is seeking experienced professionals in Indianapolis, IN, for leadership roles in synthetic molecule design and development. Candidates will oversee teams involved in the commercialization of drug candidates and define processes supporting clinical trials and regulatory submissions.

Ideal candidates possess a Ph.D. in organic chemistry with extensive experience in pharmaceutical process development. The position demands strong leadership capabilities and familiarity with contemporary analytical techniques and PAT.

Qualifications

• 10+ years of pharmaceutical process development experience with a Ph.D., or 15+ years with an MS.
• Experience with active ingredient development and regulatory submissions.

Responsibilities

• Lead synthetic molecule route commercialization and process optimization.
• Collaborate across internal networks to deliver materials for clinical trials.

Skills

Pharmaceutical process development

Synthetic organic and process chemistry techniques

Leadership capabilities

Analytical techniques and process analytical technologies (PAT)

Education

Ph.D. in organic chemistry

MS in Organic Chemistry

Tools

Modeling and simulation tools

Data analytics

Job description

Initial Therapeutics, Inc. is seeking experienced professionals in Indianapolis, IN, for leadership roles in synthetic molecule design and development. Candidates will oversee teams involved in the commercialization of drug candidates and define processes supporting clinical trials and regulatory submissions.

Ideal candidates possess a Ph.D. in organic chemistry with extensive experience in pharmaceutical process development. The position demands strong leadership capabilities and familiarity with contemporary analytical techniques and PAT.